<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Semisynthesis of segmentally isotope-labeled and site-specifically palmitoylated CD44 cytoplasmic tail</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2024-01-28">28 January 2024</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Dominik</forename><forename type="middle">P</forename><surname>Vogl</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Faculty of Chemistry</orgName>
								<orgName type="department" key="dep2">Institute of Biological Chemistry</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Währinger Str. 38</addrLine>
									<postCode>1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Vienna Doctoral School in Chemistry (DoSChem)</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Währinger Str. 42</addrLine>
									<postCode>1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Borja</forename><surname>Mateos</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Max Perutz Laboratories</orgName>
								<address>
									<addrLine>Vienna Biocenter Campus 5</addrLine>
									<postCode>1030</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mario</forename><surname>Migotti</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Max Perutz Laboratories</orgName>
								<address>
									<addrLine>Vienna Biocenter Campus 5</addrLine>
									<postCode>1030</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Doctoral School</orgName>
								<orgName type="institution" key="instit1">Vienna BioCenter PhD Program</orgName>
								<orgName type="institution" key="instit2">University of Vienna and Medical University of Vienna</orgName>
								<address>
									<postCode>A-1030</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><surname>Felkl</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Faculty of Chemistry</orgName>
								<orgName type="department" key="dep2">Institute of Biological Chemistry</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Währinger Str. 38</addrLine>
									<postCode>1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><forename type="middle">C</forename><surname>Conibear</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Applied Synthetic Chemistry</orgName>
								<address>
									<addrLine>Getreidemarkt 9</addrLine>
									<postCode>1060</postCode>
									<settlement>Wien, Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><surname>Konrat</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Max Perutz Laboratories</orgName>
								<address>
									<addrLine>Vienna Biocenter Campus 5</addrLine>
									<postCode>1030</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Christian</forename><forename type="middle">F W</forename><surname>Becker</surname></persName>
							<email>christian.becker@univie.ac.at</email>
							<affiliation key="aff1">
								<orgName type="department">Vienna Doctoral School in Chemistry (DoSChem)</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Währinger Str. 42</addrLine>
									<postCode>1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Semisynthesis of segmentally isotope-labeled and site-specifically palmitoylated CD44 cytoplasmic tail</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2024-01-28">28 January 2024</date>
						</imprint>
					</monogr>
					<idno type="MD5">398152A9DA0E446E978FFFD75DCA818B</idno>
					<idno type="DOI">10.1016/j.bmc.2024.117617</idno>
					<note type="submission">Received 30 November 2023; Received in revised form 19 January 2024; Accepted 26 January 2024</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2024-06-12T11:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Protein semisynthesis Protein lipidation Segmental isotope labeling CD44 Protein NMR Paramagnetic Relaxation Enhancement (PRE) Solid phase peptide synthesis Native chemical ligation</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>CD44, a ubiquitously expressed transmembrane receptor, plays a crucial role in cell growth, migration, and tumor progression. Dimerization of CD44 is a key event in signal transduction and has emerged as a potential target for anti-tumor therapies. Palmitoylation, a posttranslational modification, disrupts CD44 dimerization and promotes CD44 accumulation in ordered membrane domains. However, the effects of palmitoylation on the structure and dynamics of CD44 at atomic resolution remain poorly understood. Here, we present a semisynthetic approach combining solid-phase peptide synthesis, recombinant expression, and native chemical ligation to investigate the impact of palmitoylation on the cytoplasmic domain (residues 669-742) of CD44 (CD44ct) by NMR spectroscopy. A segmentally isotope-labeled and site-specifically palmitoylated CD44 variant enabled NMR studies, which revealed chemical shift perturbations and indicated local and long-range conformational changes induced by palmitoylation. The long-range effects suggest altered intramolecular interactions and potential modulation of membrane association patterns. Semisynthetic, palmitoylated CD44ct serves as the basis for studying CD44 clustering, conformational changes, and localization within lipid rafts, and could be used to investigate its role as a tumor suppressor and to explore its therapeutic potential.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>CD44 (or Cluster of-Differentiation-44 protein) is ubiquitously expressed as a variety of isoforms in adult as well as fetal tissues. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> First described in 1983 as lymphocyte homing receptor, <ref type="bibr" target="#b2">3</ref> CD44 is now known to act as the main transmembrane surface receptor of hyaluronic acid. <ref type="bibr" target="#b3">4</ref> Its conserved form consists of three protein domains and is termed standard CD44 (CD44s). Its extracellular domain is followed by a single transmembrane helix and an intrinsically disordered, cytoplasmatic Cterminal tail. <ref type="bibr" target="#b4">5</ref> The latter is subject to posttranslational modification (PTM) events such as phosphorylation, <ref type="bibr" target="#b5">6</ref> palmitoylation <ref type="bibr" target="#b6">7</ref> and proteolytic processing. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref> CD44 receptor-ligand interactions usually occur in the extracellular domain, modulating both cell growth and migration in healthy as well as in diseased states. <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11</ref> In addition to hyaluronic acid, interacting ligands include osteopontin, collagens and matrix metalloproteases, amongst many other extracellular matrix components. <ref type="bibr" target="#b1">2</ref> The globular ectodomain undergoes significant alternative splicing events, resulting in exon insertion and generation of multiple CD44 isoform variants, which show elevated expression levels in a variety of human carcinomas. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14</ref> Most CD44 receptors exist as homodimers at the cell surface. Both the transmembrane and cytoplasmatic domain of the protein are involved in the clustering of this receptor at the membrane. <ref type="bibr" target="#b14">15</ref> The homodimers play a key role in signal transduction and facilitate tumor progression, <ref type="bibr" target="#b15">16</ref> which makes this dimerization process a promising target for anti-tumor therapies. <ref type="bibr" target="#b16">17</ref> On a molecular level, CD44 homodimerization is stabilized by the formation of two disulfide bonds. The cysteine residues involved in disulfide formation are located in close proximity to each other in the transmembrane (Cys667) and the adjacent intracellular C-terminal domain (Cys676). <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b17">18</ref> Both cysteine residues can be Spalmitoylated <ref type="bibr" target="#b6">7</ref> -a PTM defined by reversible attachment of a saturated C16 fatty acid to a Cys residue. <ref type="bibr" target="#b18">19</ref> Covalent attachment of the lipid, via a thioester linkage to the cysteine sidechain located at the juxtamembrane domains, disrupts the dimerization and higher order structure (oligomers) of CD44 at the membrane (Fig. <ref type="figure">1a,</ref><ref type="figure">c</ref>). <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b19">20</ref> CD44 palmitoylation leads to accumulation of the protein in cholesterol-enriched ordered membrane subdomains, termed lipid rafts. <ref type="bibr" target="#b20">21</ref> Previously, CD44 has been described as a tumor suppressor <ref type="bibr" target="#b21">22</ref> as well as an oncoprotein <ref type="bibr" target="#b22">23</ref> in a broad range of cancers, highlighting its role in oncogenesis. <ref type="bibr" target="#b15">16</ref> Palmitoylated CD44 located in lipid rafts appears to be detrimental for the migration behavior of breast cancer cells. <ref type="bibr" target="#b15">16</ref> Therefore, posttranslationally modified CD44 may act as a novel therapeutic agent in cancer metastasis and merits a detailed investigation. <ref type="bibr" target="#b15">16</ref> Site-selectively palmitoylated proteins are not easily available from natural sources. In nature, protein palmitoylation is often carried out by palmitoyl transferases and their in vitro use can be challenging and often impractical when trying to install a lipid modification on a protein of interest. <ref type="bibr" target="#b18">19</ref> Furthermore, the purification of lipidated protein from cellular extracts is difficult because of the need to separate it from the insoluble cell fractions. Alternatively, solid-phase peptide synthesis (SPPS) and peptide ligation techniques can be employed to assemble proteins with PTMs such as palmitoylation. SPPS offers access to lipopeptides, either by coupling of pre-lipidated residues to a peptide chain or by post-synthetic lipidation of unprotected amino acids such as Cys. <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25</ref> Preparation of lipopeptides with palmitoylation on amino groups (N-terminal or sidechain) is rather straightforward and can be achieved by direct condensation of palmitic acid using standard SPPS coupling conditions, resulting in an amide linkage. <ref type="bibr" target="#b25">26</ref> S-palmitoylation, on the other hand, requires finely tuned conditions because the thioester linkage is prone to hydrolysis. <ref type="bibr" target="#b26">27</ref> In general, during synthesis of lipopeptides, an increasing chain length correlates with a decrease in solubility and poor elution profiles during HPLC purifications. <ref type="bibr" target="#b27">28</ref> Lipoproteins that are challenging to prepare or exceed the size limit of SPPS (typically ~50 residues), can be derived by peptide/protein ligation strategies such as native chemical ligation (NCL) <ref type="bibr" target="#b28">29</ref> and expressed protein ligation (EPL; Fig. <ref type="figure">1b</ref>). <ref type="bibr" target="#b29">30</ref> Originally developed by <ref type="bibr">Dawson et al. in 1994, 29</ref> NCL yields a native amide bond at the ligation site and is widely used for its ease of application and precision in chemical protein synthesis. <ref type="bibr" target="#b30">31</ref> In combination with EPL, NCL chemistry enables assembly of semisynthetic proteins, in which a recombinantly expressed protein segment is ligated to a synthetic segment that carries a site-specific PTM. Today's protein chemistry toolbox encompasses a broad range of extensions to NCL, EPL and protein semisynthesis. <ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref> One of the most significant extensions has been the development of desulfurization chemistry to convert the sulfhydryl sidechain of Cys to the more abundant Ala residue. <ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b35">36</ref> This enabled expansion of NCLbased protein synthesis to a broader range of target proteins. <ref type="bibr" target="#b36">37</ref> As CD44 is a membrane-associated intrinsically disordered protein (IDP), <ref type="bibr" target="#b37">38</ref> detailed studies of its conformational properties and dynamics at atomic resolution rely predominantly on solution techniques such as Nuclear Magnetic Resonance (NMR) experiments. <ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref> NMR can provide access to structures and dynamics of membrane-bound proteins with long and disordered regions, often unattainable by other structural biology techniques. <ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b43">44</ref> Nevertheless, such experiments require isotope labeling of the protein of interest. <ref type="bibr" target="#b44">45</ref> Biomolecular NMR relies on the spin-1/2 of 1 H, <ref type="bibr" target="#b12">13</ref> C and <ref type="bibr" target="#b14">15</ref> N, which can be incorporated by Fig. <ref type="figure">1</ref>. Domain architecture of membrane-incorporated, CD44 dimer and palmitoylated CD44 monomer and semisynthesis scheme. a) The three-domain structure of CD44 in its dimeric (disulfide bonds at Cys667 and Cys676; orange) and in its monomeric form bearing palmitoylations at Cys667 and Cys676 (orange) is shown. CD44 extracellular and transmembrane domains are followed by a variable stem region (purple) and its C-terminal cytoplasmatic domain (CD44ct(669-742)), which is the subject of our semisynthetic approach. b) Semisynthetic strategy for the generation of palmitoylated CD44ct(669-742). Recombinant expression of CD44ct(690-742) (red) allowed uniform incorporation of NMR-active <ref type="bibr" target="#b12">13</ref> C and <ref type="bibr" target="#b14">15</ref> N isotopes. Chemical synthesis gave access to the N-terminal CD44ct(669-689) (gray) peptide containing a single palmitoylation at Dap676 (Dap replaces the native cysteine residue to allow chemically stable palmitoylation via amide formation). Protein segments with natural isotope abundance are shown in grey and isotope-enriched segments in red. c) Amino acid sequence of palmitoylated CD44ct(669-742) highlighting key residues (palmitoylated Cys676 (orange) and NCL ligation site Ala690 (blue).</p><p>supplementing the expression growth media with required precursor molecules for isotopic labeling. <ref type="bibr" target="#b45">46,</ref><ref type="bibr" target="#b46">47</ref> Typically, this yields proteins that differ only in their isotopic composition ( 13 C and 15 N isotopologues), <ref type="bibr" target="#b45">46</ref> and can be used to characterize IDPs. <ref type="bibr" target="#b47">48</ref> However, protein NMR spectra of larger proteins or IDPs often results in significant signal overlap. Isotope labeling strategies, such as segmental labeling (Fig. <ref type="figure">1b</ref>), <ref type="bibr" target="#b48">49</ref> can help to reduce spectral crowding <ref type="bibr" target="#b46">47</ref> and often make use of protein ligation techniques such as NCL, also allowing incorporation of specific modifications. <ref type="bibr" target="#b46">47</ref> Here we employ protein semisynthesis to link a recombinantly expressed isotope-enriched protein segment with a chemically synthesized palmitoylated peptide, to give a fully homogeneous modified CD44ct. NMR provides insights into the effects of this PTM on the structure and dynamics of palmCD44ct(669-742).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Results &amp; discussion</head><p>To site-specifically palmitoylate CD44ct and to introduce an isotopelabeled segment, we split the cytoplasmic domain into two segments: a synthetic segment (palmCD44ct(669-689)) and a recombinant segment (CD44ct(690-742)) (Figs. <ref type="figure">1b</ref> and<ref type="figure" target="#fig_1">3a</ref>). The synthetic segment allows facile incorporation of the palmitoyl group during SPPS. However, preservation of the native palmitoyl thioester linkage at residue Cys676 is challenging under standard NCL reaction conditions because the thioester reacts with the thiol additive <ref type="bibr" target="#b27">28</ref> and can hydrolyze during handling and NMR measurements, so we substituted the native Cys676 with L-2,3-diaminopropionic acid (Dap) to form a stable amide linkage between sidechain and palmitoyl moiety. The recombinant segment was expressed with a hexa-histidine tag (6xHis) at the C-terminus for purification purposes. The N-terminal methionine was removed by the methionyl-aminopeptidases present in the E. coli expression strain, thereby releasing the N-terminal cysteine required for ligation. NCL to the synthetic segment provided access to a homogeneous palmitoylated <ref type="bibr" target="#b12">13</ref> C and <ref type="bibr" target="#b14">15</ref> N isotope-labeled CD44ct.</p><p>Upon successful cloning, transformation and expression of the gene construct, we purified unlabeled as well as isotope-enriched CD44ct (690-742). <ref type="bibr" target="#b8">9</ref> Overall, we obtained similar yields and purities for our construct to those previously reported. <ref type="bibr" target="#b8">9</ref> The 1 H-15 N-HSQC NMR spectra of isotope-labelled CD44ct(690-742) were compared with spectra of CD44ct(669-742) <ref type="bibr" target="#b8">9</ref> and showed nearly identical 1 H-15 N correlation NMR fingerprints (Fig. <ref type="figure" target="#fig_0">2a</ref>), except for the N-terminal residues not present in truncated CD44ct (missing aa 669-689) and the presence of an affinity tag (His 6 tag) at the C-terminus. <ref type="bibr" target="#b8">9</ref> Synthesis of palmCD44ct(669-689), carrying a single palmitoylation at residue 676, was achieved by Fmoc-based SPPS chemistry on a Oamino(methyl)aniline (MeDbz) NovaSyn®TGR resin. <ref type="bibr" target="#b49">50</ref> The MeDbz resin allows the controlled preparation of C-terminal thioester peptides similarly to alternative chemistries such as the use of C-terminal hydrazides. <ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref> The C-terminal MeDbz moiety can be transformed into an activated N-acyl-N'-methyl-benzimidazolinone (MeNbz) moiety after peptide assembly and subsequently enables conversion into a C-terminal thioester for NCL. <ref type="bibr" target="#b53">54</ref> After assembly of palmitoylated CD44ct(669-689) on the solid phase, the C-terminal MeDbz moiety was activated with p-nitrophenyl chloroformate, yielding resin-bound palmCD44ct(669-689)-MeNBz. <ref type="bibr" target="#b49">50</ref> Final cleavage and preparative HPLC purification resulted in 19 mg of palmCD44ct(669-689)-MeNBz peptide with a purity of more than 95 % for subsequent ligation reactions (Fig. <ref type="figure" target="#fig_0">2b</ref> and<ref type="figure" target="#fig_1">3d</ref>).</p><p>The synthetic peptide palmCD44ct(669-689)-MeNbz was converted into the corresponding thioester followed by ligation with isotopelabeled CD44ct(690-742) at a concentration of 2 mM and cysteine desulfurization, all carried out in a one-pot reaction. MesNa (sodium 2mercaptoethanesulfonate) was used as thiol additive for the N-acylurea to thioester conversion and ligation reaction as it is compatible with desulfurization conditions (Fig. <ref type="figure" target="#fig_1">3a</ref>). <ref type="bibr" target="#b49">50,</ref><ref type="bibr" target="#b54">55,</ref><ref type="bibr" target="#b55">56</ref> The ligation was monitored via analytical RP-HPLC and LC-MS (Fig. <ref type="figure" target="#fig_1">3b</ref>). After 9 h, desulfurization was initiated by adding water-soluble VA-044 as radical initiator in presence of neutralized TCEP, DTT and MesNa as the H-donor. Desulfurization ran for 6 h and converted Cys690 (required for NCL) into native Ala690, yielding the desired desulfurized product palmCD44ct (669-742) (Fig. <ref type="figure" target="#fig_1">3</ref>). <ref type="bibr" target="#b35">36</ref> We obtained 3.2 mg of desulfurized, segmentally isotope-labeled palmCD44ct(669-742) (~40 % overall yield over two steps) with a purity of &gt;95 % (Fig. <ref type="figure" target="#fig_1">3c,</ref><ref type="figure">d</ref>). We then further characterized the non-desulfurized reaction intermediate and our semisynthetic palmCD44ct(669-742) product by gel electrophoresis without reducing agents. As expected, we observed disulfide formation for the Cyscontaining reaction intermediate giving rise to CD44ct dimers, whereas the desulfurized product did not form dimers (Fig. <ref type="figure" target="#fig_1">3c</ref>).</p><p>Having semisynthetic, segmentally isotope labeled palmCD44ct in hand, we dissolved the lyophilized protein in NMR buffer and 1 H- <ref type="bibr" target="#b14">15</ref> N correlation NMR spectra of palmCD44ct were acquired (Fig. <ref type="figure" target="#fig_2">4</ref>). <ref type="bibr" target="#b8">9</ref> We observed lower solubility of our palmitoylated variant compared to recombinantly expressed CD44ct(669-742) due to palmitoylation. The overall decrease in signal intensities of the segmentally labelled variant was a very likely a result of micelle formation in solution due to the amphiphilic character of palmCD44ct. The 1 H- <ref type="bibr" target="#b14">15</ref> N HSQC NMR spectra were acquired for semisynthetic palmCD44ct (Fig. <ref type="figure" target="#fig_2">4c</ref>) and chemical shifts were compared with unmodified CD44ct(669-742) (Fig. <ref type="figure" target="#fig_2">4b</ref>). The backbone amide resonances of residues 669 to 689 in our semisynthetic variant cannot be observed in the 1 H-15 N-HSQC spectrum, as the synthetic segment is not <ref type="bibr" target="#b14">15</ref> N-and 13 C-enriched. Overlay of the respective 1 H- <ref type="bibr" target="#b14">15</ref> N-HSQC spectra of unmodified <ref type="bibr" target="#b8">9</ref> with palmCD44ct shows similar NMR fingerprints for backbone amide resonance signals for residues 690 to 738 (Fig. <ref type="figure" target="#fig_2">4c</ref>). This suggests that the protein remains intrinsically disordered in the lipidated form. However, the palmitoylation induced small but significant chemical shift perturbations in the HSQC spectra, corrected for the presence of the His 6 tag, (Fig. <ref type="figure" target="#fig_2">4b</ref>). These chemical shift perturbations were compared with intramolecular paramagnetic relaxation enhancement (PRE) measurements, which provided evidence for the existence of transient tertiary contacts in the unmodified CD44ct (Fig. <ref type="figure" target="#fig_3">5</ref>). The chemical shift perturbations were larger in the region (residues 710-716) where intramolecular contacts were observed on the PRE measurements, suggesting a possible impact of palmitoylation on the (transient) formation of compact states before membrane attachment. Palmitoylation might therefore modulate the conformational ensemble of CD44ct by stabilizing long-range contacts that are only partly formed in the unmodified state, and which might influence membrane insertion.</p><p>PTMs, such as the addition of palmitoylation to a side chain, can cause long-range perturbations in the chemical environment of backbone residues. <ref type="bibr" target="#b56">57</ref> Remarkably, those effects can be located at a large distance from the actual PTM and are a common feature in IDPs. <ref type="bibr" target="#b48">49,</ref><ref type="bibr" target="#b57">58,</ref><ref type="bibr" target="#b58">59,</ref><ref type="bibr" target="#b59">60</ref> Our results suggest a slightly altered conformation of CD44 upon palmitoylation, which might lead to differences in conformation and dynamics in its free as well as in its membrane-bound form. Therefore, palmitoylation of Cys676 has the potential to disrupt formation of carcinogenic CD44 homodimers, and might also lead to altered intramolecular and membrane interaction patterns. 16  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Summary &amp; conclusion</head><p>In this work we utilize protein semisynthesis to generate the cytoplasmatic domain of CD44 bearing a site-specific PTM and to segmentally isotope label our protein of interest. Furthermore, we provide insights into the effects of palmitoylation on palmCD44ct(669-742) conformation by NMR spectroscopy. Palmitoylation of Cys676 has been shown to be necessary for subsequent lipid raft association. <ref type="bibr" target="#b19">20</ref> Therefore, its role might be crucial in controlling CD44′s dual role as a tumor suppressor as well as an oncoprotein. Previous experiments have clearly shown that lipidation of Cys676 abolishes the ability of CD44 to dimerize. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref> In addition, fluorescence based characterization of CD44 on living cells enabled a coarse structural analysis of such CD44 clusters, <ref type="bibr" target="#b60">61</ref> but molecular details of these (sub-)raft structures remains elusive so far. Our synthetic route provides a new starting point for studies on the importance of CD44 lipidation events, the effects on protein structure and its clustering patterns on membranes, and has the potential to increase our knowledge about the role of CD44 in certain cancers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Materials &amp; methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1.">Reagents &amp; chemicals</head><p>Fmoc (9-fluorenylmethyloxycarbonyl) and orthogonally protected amino acids were obtained from Iris Biotech GmbH, Marktredwitz, Germany.</p><p>1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU) and 2-(1H-Benzotriazole-1yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) were purchased from GL Biochem, Shanghai, China. Diisopropylethyl amine (DIPEA), triisopropylsilane (TIS), trifluoroacetic acid (TFA), sodium 2mercaptoethanesulfonate (MesNa), guanidine hydrochloride (Gdn-HCl), piperidine, palmitoyl chloride, 1-Hydroxybenzotriazole (HOBt), triethylamine, p-nitrophenyl chloroformate and MeDbz NovaSyn®TGR resin were purchased from Sigma-Aldrich. N,N-dimethylformamide (DMF), dichloromethane (DCM), acetonitrile (ACN) were purchased from Biosolve (Valkenswaard, The Netherlands). VA-44 was obtained from TCl Chemicals (Germany). All other chemical reagents and solvents were purchased in the highest available purity from the following sources: Sigma-Aldrich (Taufkirchen, Germany), Fisher-Scientific (Schwerte, Germany), TCI-Europe (Zwijndrecht, Belgium), VWR (Darmstadt, Germany), Roth (Karlsruhe, Germany), Merck (Darmstadt, Germany), Invitrogen (Darmstadt, Germany), J.T.Baker (Griesheim, Germany), NeoLab (Heidelberg, Germany) or Omnilab (Bremen, Germany). Recombinant Expression of CD44ct(690-742) was performed as described previously. <ref type="bibr" target="#b8">9</ref> The E. coli expression strain BL21 (DE3) carried a pETM-11 expression vector coding for a CD44ct(690-742)-His 6 fusion protein. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b61">62</ref> Expression was carried out using LB media (unlabeled expression) or minimal medium supplemented with suitable precursor molecules (for <ref type="bibr" target="#b12">13</ref> C/ 15 N isotopic labeling). <ref type="bibr" target="#b62">63</ref> Bacterial overnight cultures were grown in LB medium until they reached an OD600 of 0.8. For isotopic labeling, cells were harvested by centrifugation at 4000 rpm and 4 • C for 15 min and resuspended in minimal medium. To induce expression, IPTG was added at a final concentration of 1 mM after an equilibration period of 10 min at 37 • C. Following induction, the culture was incubated at 28 • C with appropriate agitation for 18 h. Afterwards, the cells were harvested by centrifugation at 4000 rpm and 4 • C for 20 min. Bacterial pellets were resuspended in 40 mL washing buffer (50 mM Tris-HCl, 300 mM NaCl, pH 8) per liter expression culture supplemented with Halt™ Protease Inhibitor Cocktail (Thermo Scientific™) and 2 mM β-mercaptoethanol. Cell lysis was achieved through sonication, followed by centrifugation at 18,000 rpm and 4 • C for 40 min. The supernatant containing CD44ct(690-742)-His 6 was transferred to a round flask and stirred at 80 • C for 10 min until white precipitation was visible. Then the mixture was centrifuged at 18,000 rpm and 4 • C for 40 min. Subsequently, the supernatant was loaded onto a HisTrap™ High-Performance (GE Healthcare) affinity chromatography column preloaded with Ni 2+ ions. After equilibration (with 50 mM Tris-HCl) the column was washed with at least 3 column volumes of a low imidazole buffer (50 mM Tris-HCl, 1000 mM NaCl, 20 mM imidazole, pH 8) and reequilibrated with washing buffer. Elution was performed using an elution buffer containing 50 mM Tris-HCl (300 mM NaCl, 500 mM imidazole, pH 8) with a successively increasing gradient. Afterwards all collected fractions containing CD44ct(690-742) were combined and concentrated using a 3 kDa cutoff Amicon® Ultra Centrifugal Filter (Merck). The concentrated protein was loaded onto a HiLoad® 16/600 Superdex® 75 pg column pre-equilibrated with 50 mM sodium phosphate buffer (50 mM NaCl, 0.02 % NaN 3 , pH 6.5) and subjected to size exclusion chromatography using the same buffer. The collected fractions containing the CD44ct(690-742) were pooled and concentrated using a 3 kDa cutoff Amicon® Ultra Centrifugal Filter (Sigma) until a concentration of approximately 0.7-0.9 mM was reached. Concentration was determined using BCA Protein Assay (Thermo Scientific™) and measurements of free thiol via the 5,5′-dithio-bis-[2-nitrobenzoic acid] reaction (Thermo Scientific™). Samples were frozen in liquid nitrogen and kept at -20 • C until further usage. <ref type="bibr" target="#b8">9</ref> Analytical characterization via SDS-PAGE was performed under conditions described by Laemmli using 15 % separating gels. <ref type="bibr" target="#b63">64</ref> Sample loading was carried out in 2x SDS-loading buffer (0.5 M Tris-HCl, 6 % (w/v) SDS, 35 % (vol%) glycerol and 0.05 % (w/v) bromophenol blue, pH 6.8). Please note that SDS-loading buffer was not supplemented with β-mercaptoethanol. For gel staining and de-staining, a Coomassie solution (0.1 % (w/v) Coomassie R250, 10 % (vol%) acetic acid and 45 % (vol%) methanol in water) and de-staining solution (10 % (vol%) acetic acid and 40 % (vol%) methanol in water) were used. <ref type="bibr" target="#b64">65</ref> SPPS &amp; on-resin palmitoylation of palmCD44ct(669-689)-MeDbz: SPPS-derived peptide sequence of palmCD44ct(669-689)-MeDbz: AVNSRRRDapGQKKKLVINSGNG-MeDbz-resin</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recombinant Expression of</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Palmitoylation site: Cys to Dap mutation at amino acid residue 676 Synthesis modification: double coupling of amino acid residues</head><p>PalmCD44ct(669-689)-MeDbz was generated via Fmoc-SPPS on a commercially available MeDbz NovaSyn®TGR resin (Sigma-Aldrich). <ref type="bibr" target="#b49">50</ref> After loading of the first amino acid residue synthesis was performed on a PTI Tribute Peptide Synthesizer (Protein Technologies, Inc., USA) at room temperature. Synthesis was performed at 0.2 mmol scale using 5 eq. amino acid, 4.5 eq. activator (HBTU) and 5 eq. base (DIPEA). If required, double couplings were performed at certain positions as shown in the sequence above. Coupling time was 60 mins. Following the last amino acid residue, the resin was washed several times with DMF and DCM. While swelling the resin for 30 min in DCM, 500 mL of MTT cleavage solution (DCM/TFA/TIS, 98:1:1) were prepared. Deprotection of MTT was performed using 20 mL of cleavage solution for 2 min under constant agitation and a subsequent washing step with at least 3 syringe volumes of DCM. The latter steps were repeated in a continuous cycle (~20 times) until no color change of the solvent could be observed. As a final step, the resin was washed several times with DMF and then rinsed with 1 % (v/v) DIPEA in DCM to reach a basic pH environment for onresin palmitoylation. The resin was washed several times with DCM and finally kept in DCM for 30 min. In the meantime, 24 mL palmitoyl chain coupling solution was prepared as followed (for 0.2 mmol scale): 20 eq. palmitoyl chloride (4 mmol), 20 eq. HOBt (4 mmol), 22 eq. Triethylamine (4.4 mmol) in DCM/DMF (3:1). Palmitoylation reaction was performed overnight. The next day the resin was washed thoroughly with DMF and DCM. Subsequent activation of the MeDbz functionality was achieved using a solution of p-nitrophenyl chloroformate (100 mg, 0.5 mmol) in DCM. After 1 h the solution was drained, the resin was washed with DCM and treated with a solution of DIEA (0.5 M in DMF) for 15 min. Afterwards the resin was washed with DMF, DCM and finally dried overnight and cleaved using a standard cleavage cocktail (TFA/ TIS/H 2 O, 95:2.5:2.5) for 2 h. Then, the TFA solution containing the peptide was precipitated in Et 2 O (2x), centrifuged, dissolved in H 2 O/ ACN (50:50) and lyophilized. <ref type="bibr" target="#b49">50</ref> Preparative RP-HPLC was performed on a Waters Purification HPLC system (Waters 2545 Quarternary Gradient Module, Waters 2489 UV/Visible Detector &amp; Waters Fraction Collector III) using a Kromasil C18 column (300-10-C18, 250 x 21.2 mm, 10 μm particle size) at a flow rate of 10 mL/min, running a linear gradient of 15 % to 65 % solvent B (ACN + 0.08 % TFA) in solvent A (ddH2O + 0.1 % TFA) over 50 min, monitoring absorption at 214 and 280 nm. Fractions containing pure palmCD44ct(669-689)-MeDbz peptide were combined, frozen in liquid nitrogen, lyophilized and stored at -20 • C until further usage.</p><p>Analytical characterization of the crude (dissolved in 6 M Gdn-HCl pH 4.7) as well as purified peptides were performed as follows: RP-HPLC was performed on a Dionex Ultimate 3000 instrument using a Kromasil C18 column (300-5-C18, 150 × 4.6 mm, 5 μm particle size) at a flow rate of 1 mL/min running a linear gradient of 5 % to 65 % of solvent B (ACN + 0.08 % TFA) in solvent A (ddH2O + 0.1 % TFA) over 30 min at 30 • C, monitoring absorption at 214 and 280 nm. Analytical LC-MS as well as ESI-MS characterizations were performed on a Waters Auto Purification HPLC-MS system (equipped with 3100 Mass Detector, 2545 Binary Gradient Module, 2767 Sample Manager and 2489 UV/Visible Detector). Mass spectra were acquired by electrospray ionization (ESI) operating in positive ion mode. Separations were achieved with a Kromasil C18 column (300-5-C18, 150 × 4.6 mm, 5 μm particle size) at a flow rate of 1 mL/min while running a linear gradient of 5 % to 65 % of solvent B (ACN + 0.05 % TFA) in solvent A (ddH2O + 0.05 % TFA) in 10 min, monitoring absorption at 214 nm. Analytical characterization via SDS-PAGE was performed as described above.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2.">MesNa thioester conversion, native chemical ligation &amp; one-pot desulfurization</head><p>Buffers used for thioester conversion, ligation reactions and one-pot desulfurization reactions were degassed via argon or nitrogen purging for at least 5 min before usage. For the MesNa thioester conversion of palmCD44ct(669-689)-MeDbz, the peptide was dissolved in 6 M Gdn-HCl in 200 mM Sodium Phosphate buffer supplemented with 200 mM MesNa and 75 mM TCEP. Afterwards, the pH was adjusted to 7.5 and the solution was kept at room temperature for 10 min. In order to initiate the ligation reaction, <ref type="bibr" target="#b12">13</ref> C/ 15 N-labelled recombinant CD44ct (690-742) was directly added from the NMR stock solutions to the previously prepared ligation solution, vortexed briefly and the pH was adjusted to pH 7.5. The ligation reaction was performed at 30 • C for 9 h under constant agitation. The ligation reaction progress was monitored by LC-MS and analytical RP-HPLC. Therefore, 10 µL of ligation reaction sample was mixed with 11 µL of 5 % solvent B (ACN + 0.08 % TFA) in solvent A (ddH2O + 0.1 % TFA) and injected on both systems. Analytical RP-HPLC monitoring was performed on a Dionex Ultimate 3000 instrument using a Kromasil C18 column (see above) at a flow rate of 1 mL/min running a linear gradient of 5 % to 65 % of solvent B (ACN + 0.08 % TFA) in solvent A (ddH2O + 0.1 % TFA) over 30 min at 30 • C, monitoring absorption at 214 and 280 nm. Analytical LC-MS was performed on a Waters Auto Purification HPLC-MS system (see above). Separations were achieved with a Kromasil C18 column at a flow rate of 1 mL/min while running a linear gradient of 5 % to 65 % of solvent B (ACN + 0.05 % TFA) in solvent A (ddH2O + 0.05 % TFA) in 10 min.</p><p>Desulfurization of the segmentally labelled ligation product was performed in a one-pot manner directly after the ligation was finished. <ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b35">36</ref> Therefore, the ligation solution was mixed 1:1 (v/v) with freshly prepared desulfurization buffer. The latter consisted of 6 M Gdn-HCl in 200 mM Sodium Phosphate buffer supplemented with 350 mM TCEP, 50 mM VA-44 and 50 mM DTT at pH 6.0. The reaction was carried out at 40 • C under exclusion of light in a water bath. After 3 h the desulfurization solution was mixed 1:1 (v/v) with freshly prepared desulfurization buffer and pH was readjusted to 6.0 again before incubating the reaction for additional 3 h. The reaction was finished after 6 h. Progress of the desulfurization reaction was monitored by RP-HPLC and LC-MS with identical settings as for ligation monitoring. Prior to HPLC purification of palmCD44ct(669-742) the sample was quenched via 1:1 dilution with quenching buffer (900 µL 6 M Gdn-HCL, 100 µL β-mercaptoenthanol &amp; a few crystals of TCEP) and incubated for at least 15 min. Analytical RP-HPLC purification was performed on a Dionex Ultimate 3000 instrument using a Kromasil C18 column (see above) at a flow rate of 1 mL/min running a linear gradient of 30 % to 40 % of solvent B (ACN + 0.08 % TFA) in solvent A (ddH2O + 0.1 % TFA) over 20 min at 60 • C, monitoring absorption at 214 and 280 nm. Fractions containing the desired product were pooled, frozen in liquid nitrogen and lyophilized. Analytical characterization of the final ligation product was performed on a Dionex Ultimate 3000 instrument using a Kromasil C4 column (300-5-C4, 150 × 4.6 mm, 5 μm particle size) at a flow rate of 1 mL/min running a linear gradient of 5 % to 65 % of solvent B (ACN + 0.08 % TFA) in solvent A (ddH2O + 0.1 % TFA) over 30 min at 30 • C, monitoring absorption at 214 and 280 nm. Analytical ESI-MS characterization was performed on a Waters Auto Purification HPLC-MS system (see above) in positive ion mode. Analytical characterization via SDS-PAGE was performed as described above.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3.">NMR experiments</head><p>All NMR experiments were recorded at 20 • C (293 K) on either a Bruker 800 MHz (Avance NEO) spectrometer equipped with TXI probehead. 100 μM 15 N, <ref type="bibr" target="#b12">13</ref> C double labeled CD44ct(669-742), CD44ct (691-742) or palmCD44ct(669-742)) sample in NMR buffer (50 mM sodium phosphate, 50 mM NaCl (pH 6.5), 0.05 % (w/v) NaN 3 ) was used. The assignment experiments of the CD44ct(669-742) are described in a previous publication <ref type="bibr" target="#b8">9</ref> and the chemical shifts deposited in BMRB (ID: 27625). Data processing was carried out with qMDD for non-uniform sampled data (assignment experiments) and NMRPipe (two-dimensional 1 H-15 N correlation experiments) for all uniformly collected experiments. Data analysis was performed with CcpNmr Analysis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.4.">MTSL labeling</head><p>Purified proteins (CD44ct) containing one Cys reacted with S-(1oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl) methyl methanesulfonothioate (MTSL), containing a free electron. The protein solution was incubated for 15 min with 10 mM DTT to reduce all the cysteines. Then, the buffer was exchanged using a PD-10 column to the MTSL-tagging buffer (100 mM sodium phosphate buffer, 1 mM EDTA, pH = 8). The free-thiol concentration was measured with 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB or Ellman's reagent). The absorbance at 412 nm (Abs 412 ) was monitored to check the efficacy of the reaction. A 2.5-fold excess of MTSL was added and the incubated at 37 • C for 2-3 h until the Abs 412 is null. Then, the sample was concentrated, and buffer exchanged to the NMR buffer (without DTT or any other reducing agent). For the paramagnetic form, a 3-fold excess of ascorbic acid was added.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.5.">Intramolecular paramagnetic relaxation relaxation (PRE) enhancements</head><p>Equimolar amounts of CD44ct labelled with MTSL were mixed with</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 2 .</head><label>2</label><figDesc>Fig. 2. a) 1 H-15 N HSQC NMR spectra overlay of truncated CD44ct(690-742) (red) and full-length CD44ct(669-742) (black). b) Analytical RP-HPLC (C18) chromatogram and ESI-MS spectrum (exp. M.W.: 2680.2 Da; obs. M.W.: 2680.5 Da) of synthetic palmCD44ct(669-689) -MeNBz.</figDesc><graphic coords="3,74.21,421.02,446.83,295.63" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 3 .</head><label>3</label><figDesc>Fig. 3. a) Schematic illustration of the semisynthesis strategy for the generation of segmentally labeled palmCD44ct(669-742). Protein segments with natural isotope abundance are shown in grey and isotope-enriched segments in red. b) Monitoring of the NCL reaction progress via analytical RP-HPLC (C18) chromatogram showing formation of semisynthetic, segmentally labeled palmCD44ct(669-742) (not desulfurized). c) Characterization of purified synthetic and recombinant CD44ct segments as well as semisynthetic CD44ct products by SDS PAGE under non-reducing conditions. From left to right: (M) Marker | (1) SPPS derived palmCD44ct(669-689) -MeNbz | (2) recombinant CD44ct(690-742); unlabelled | (3) recombinant CD44ct(690-742); isotopic labelled with 13 C/ 15 N precursors | (4) semisynthetic palmCD44ct(669-742); isotopic labeled; not desulfurized | (5) semisynthetic palmCD44ct(669-742); isotopic labeled; desulfurized. d) Analytical RP-HPLC (C4) chromatogram and ESI-MS spectrum (exp. M.W. (100 % 15 N/ 13 C): 9799.6 Da; obs. M.W. (99 % 15 N/ 13 C): 9755.0 Da) of purified, segmentally labeled palmCD44ct (669-742) after desulfurization.</figDesc><graphic coords="4,64.86,55.42,465.55,532.66" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 4 .</head><label>4</label><figDesc>Fig. 4. a) Schematic illustration of recombinant CD44ct(669-742) (black) and semisynthetic, segmentally labeled palmCD44ct(669-742) (red). Protein segments with natural isotope abundance are shown in grey and isotope-enriched segments in red/black. b) Chemical shift perturbation (CSP) differences (ΔCSPs) calculated to correct for the C-terminal His 6 tag tag of the truncated CD44ct(690-742) fragment. Significant positive or negative deviations indicate local structural changes in the palmitoylated form when compared to its unmodified counterpart (CD44(669-742) c) 1 H-15 N HSQC NMR spectra of recombinant CD44ct(669-742) (black) and semisynthetic palmCD44ct(669-742) (red) at 0.1 mM concentration in 50 mM sodium phosphate buffer, 50 mM NaCl, 0.02 % NaN 3 , pH 6.5.</figDesc><graphic coords="5,76.54,432.80,442.22,255.17" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 5 .</head><label>5</label><figDesc>Fig. 5. Evidence for transiently formed long-range contacts in CD44ct. Intramolecular paramagnetic relaxation enhancement (PRE) experiments reveal spatial proximities between the spin label site Cys676 (green vertical line) and residues located in the C-terminal segment (around residue positions 712 and 728). PRE rates are given as differences between the paramagnetic (MTSLtagged) and diamagnetic state (after reduction with ascorbic acid). Possible intermolecular contributions to the measured PREs were ruled out by control experiments with 14 N-MTSL-labelled CD44ct and untagged (without MTSL spin label) 15 N-CD44ct.</figDesc><graphic coords="5,309.83,55.44,244.66,175.25" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc>CD44ct(690-742): Translated amino acid sequence of recombinant CD44ct(690-742)-His 6 fusion protein: MCysVEDRKPSGLNGEASKSQEMVHLVNKESSETPDQFMTA-DETRNLQNVDMKIGVLEHHHHHH Native Chemical Ligation Site: Ala to Cys mutation at amino acid residue 690</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="2,65.14,359.62,464.98,299.66" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>Bioorganic &amp; Medicinal Chemistry 100 (2024) 117617</p></note>
		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data availability</head><p>Data will be made available on request.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"> <ref type="bibr" target="#b14">15</ref> <p>N-labelled CD44ct where all the thiol groups are protected with iodoacetamide. The 1 H N -R 2 rates for both the paramagnetic and diamagnetic forms were acquired in a Bruker Advance III HD + 800 MHz spectrometer at 298 K. The pulse sequence used was a pseudo-3D 1 H-T 2 HSQC. Six relaxation delays (pseudo-dimensions) were acquired to fit an exponential decay function (0.001, 0.005, 0.01, 0.02, 0.05 and 0.1 s) and extract the 1 H-R 2 (R 2 = 1/T 2 ). </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CRediT authorship contribution statement</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Declaration of competing interest</head><p>The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Christian F.W. Becker, Robert Konrat and Anne C. Conibear report financial support was provided by Vienna Science and Technology Fund (WWTF, grant number LS17-008). If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zoller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="254" to="267" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Senbanjo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Chellaiah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Cell Dev Biol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">18</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">A cell-surface molecule involved in organspecific homing of lymphocytes</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Gallatin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Weissman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Butcher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">304</biblScope>
			<biblScope unit="page" from="30" to="34" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">CD44 cell adhesion molecules</title>
		<author>
			<persName><forename type="first">S</forename><surname>Goodison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Urquidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tarin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Pathol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="189" to="196" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Cell adhesion molecule CD44: its functional roles in prostate cancer</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Iczkowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Transl Res</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Interleukin-1beta-induced Reduction of CD44 Ser-325 phosphorylation in human epidermal keratinocytes promotes CD44 homomeric complexes, binding to ezrin, and extended, monocyte-adhesive hyaluronan coats</title>
		<author>
			<persName><forename type="first">T</forename><surname>Jokela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Oikari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Takabe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="page" from="12379" to="12393" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Molecular mechanism for bidirectional regulation of CD44 for lipid raft affiliation by palmitoylations and PIP2</title>
		<author>
			<persName><forename type="first">F</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cfe</forename><surname>Schroer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Palacios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S-Z</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Marrink</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Comput Biol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">1007777</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Inside-out regulation of ectodomain cleavage of cluster-of-differentiation-44 (CD44) and of neuregulin-1 requires substrate dimerization</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hartmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Parra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ruschel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="page" from="17041" to="17054" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Konrat R. 1H, 15N, 13C resonance assignment of the human CD44 cytoplasmic tail (669-742)</title>
		<author>
			<persName><forename type="first">B</forename><surname>Fruhbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mateos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomol NMR Assign</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="109" to="113" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ashkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Glimcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cantor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="509" to="512" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Chapter Ten -Hyaluronan-CD44 Interaction Promotes Oncogenic Signaling, microRNA Functions, Chemoresistance, and Radiation Resistance in Cancer Stem Cells Leading to Tumor Progression</title>
		<author>
			<persName><forename type="first">Lyw</forename><surname>Bourguignon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shiina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Advances in Cancer Research</title>
		<editor>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Simpson</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">P</forename><surname>Heldin</surname></persName>
		</editor>
		<imprint>
			<publisher>Academic Press</publisher>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="255" to="275" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">CD44 is the principal cell surface receptor for hyaluronate</title>
		<author>
			<persName><forename type="first">A</forename><surname>Aruffo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Stamenkovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Melnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Underhill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Seed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1303" to="1313" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Screaton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Cornelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Gerth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Bell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PNAS</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="12160" to="12164" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">CD44 isoforms during differentiation and development</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ruiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schwärzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Günthert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioessays</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="17" to="24" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Molecular mechanism of CD44 homodimerization modulated by palmitoylation and membrane environments</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biophys J</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="2671" to="2683" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Mcsherry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Donatello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Adk</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Hopkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Breast Cancer Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">R19</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">A low MW inhibitor of CD44 dimerization for the treatment of glioblastoma</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="3009" to="3023" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid</title>
		<author>
			<persName><forename type="first">D</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Sy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="1987" to="1994" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies</title>
		<author>
			<persName><forename type="first">H</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Aramsangtienchai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem Rev</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="919" to="988" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Thankamony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Knudson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="page" from="34601" to="34609" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Lipid rafts as a membrane-organizing principle</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lingwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Simons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">327</biblScope>
			<biblScope unit="page" from="46" to="50" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The role of metastasis suppressor genes in metastatic dormancy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Horak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-C</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Shreeve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Steeg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">APMIS</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="586" to="601" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers</title>
		<author>
			<persName><forename type="first">E</forename><surname>Olsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Honeth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P-O</forename><surname>Bendahl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">418</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Discovery, synthesis, and optimization of peptide-based antibiotics</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">O</forename><surname>Hermant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pwr</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Brimble</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acc Chem Res</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1878" to="1890" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Labeling and natural posttranslational modification of peptides and proteins via chemoselective Pd-catalyzed prenylation of cysteine</title>
		<author>
			<persName><forename type="first">T</forename><surname>Schlatzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kriegesmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schroder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="14931" to="14937" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Peptide ligations by using aryloxycarbonyl-o-methylaminoanilides: chemical synthesis of palmitoylated sonic hedgehog</title>
		<author>
			<persName><forename type="first">J</forename><surname>Pala-Pujadas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Albericio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Blanco-Canosa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="16120" to="16125" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Lipidated ras and rab peptides and proteins-synthesis, structure, and function</title>
		<author>
			<persName><forename type="first">L</forename><surname>Brunsveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kuhlmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Alexandrov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wittinghofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Goody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Waldmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="6622" to="6646" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Chemical synthesis and semisynthesis of lipidated proteins</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kriegesmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dowman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Payne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Synthesis of proteins by native chemical ligation</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Muir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Clark-Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">266</biblScope>
			<biblScope unit="page" from="776" to="779" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Expressed protein ligation: a general method for protein engineering</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Muir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sondhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Cole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="6705" to="6710" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Native chemical ligation in protein synthesis and semi-synthesis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Conibear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Payne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cfw</forename><surname>Becker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem Soc Rev</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="9046" to="9068" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Expanding the chemical toolbox for the synthesis of large and uniquely modified proteins</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bondalapati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jbara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Chem</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="407" to="418" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Native chemical ligation and extended methods: mechanisms, catalysis, scope, and limitations</title>
		<author>
			<persName><forename type="first">V</forename><surname>Agouridas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">El</forename><surname>Mahdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Diemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cargoet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Monbaliu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Melnyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem Rev</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="7328" to="7443" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Chemoenzymatic semisynthesis of proteins</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Muir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem Rev</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="3051" to="3126" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Synthesis of peptides and proteins without cysteine residues by native chemical ligation combined with desulfurization</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Z</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Dawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="526" to="533" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Free-radical-based, specific desulfurization of cysteine: a powerful advance in the synthesis of polypeptides and glycopolypeptides</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Danishefsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="9248" to="9252" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Native chemical ligation combined with desulfurization and deselenization: a general strategy for chemical protein synthesis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Dawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Isr J Chem</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="862" to="867" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Membrane bending by protein-protein crowding</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stachowiak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Ryan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Cell Biol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="944" to="949" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Perspective: the essential role of NMR in the discovery and characterization of intrinsically disordered proteins</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Dyson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Wright</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biomol NMR</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="651" to="659" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Intrinsically disordered proteins in cellular signalling and regulation</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Dyson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="18" to="29" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">NMR contributions to structural dynamics studies of intrinsically disordered proteins</title>
		<author>
			<persName><forename type="first">R</forename><surname>Konrat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Magn Reson</title>
		<imprint>
			<biblScope unit="volume">241</biblScope>
			<biblScope unit="page" from="74" to="85" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Modulation of intrinsically disordered protein function by post-translational modifications</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Forman-Kay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="6696" to="6705" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The intracellular lipidbinding domain of human Na(+)/H(+) exchanger 1 forms a lipid-protein costructure essential for activity</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hendus-Altenburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vogensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Pedersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Commun Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">731</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Order and disorder-An integrative structure of the full-length human growth hormone receptor</title>
		<author>
			<persName><forename type="first">N</forename><surname>Kassem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Araya-Secchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bugge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Adv</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">3805</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Macromolecular NMR spectroscopy for the non-spectroscopist</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Kwan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mobli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Gooley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Mackay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="687" to="703" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Isotope-labeling strategies for solution NMR studies of macromolecular assemblies</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Ingen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Struct Biol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="75" to="82" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Segmental and site-specific isotope labelling strategies for structural analysis of posttranslationally modified proteins</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Vogl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Conibear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cfw</forename><surname>Becker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">RSC Chem Biol</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">NMR Spectroscopic Studies of the Conformational Ensembles of Intrinsically Disordered Proteins</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kurzbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kontaxis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Coudevylle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Konrat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Intrinsically Disordered Proteins Studied by NMR Spectroscopy</title>
		<editor>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Felli</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">R</forename><surname>Pierattelli</surname></persName>
		</editor>
		<meeting><address><addrLine>Cham</addrLine></address></meeting>
		<imprint>
			<publisher>Springer International Publishing</publisher>
			<biblScope unit="volume">2015</biblScope>
			<biblScope unit="page" from="149" to="185" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Site-specific modification and segmental isotope labelling of HMGN1 reveals long-range conformational perturbations caused by posttranslational modifications</title>
		<author>
			<persName><forename type="first">G</forename><surname>Niederacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Urwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Dijkwel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">RSC Chem Biol</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Chemical protein synthesis using a second-generation N-acylurea linker for the preparation of peptide-thioester precursors</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Blanco-Canosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nardone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Albericio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Dawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="7197" to="7209" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Protein chemical synthesis by ligation of peptide hydrazides</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="7645" to="7649" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Chemical synthesis of proteins using peptide hydrazides as thioester surrogates</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Protoc</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2483" to="2495" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Acyl donors for native chemical ligation</title>
		<author>
			<persName><forename type="first">B</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Chem Biol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="33" to="40" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">An efficient Fmoc-SPPS approach for the generation of thioester peptide precursors for use in native chemical ligation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Blanco-Canosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Dawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="6851" to="6855" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Site-specific glycation of human heat shock protein (Hsp27) enhances its chaperone activity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Vogl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cfw</forename><surname>Becker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Chem Biol</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Chemical protein synthesis using a second-generation &lt;i&gt;N&lt;/i&gt; -acylurea linker for the preparation of peptide-thioester precursors</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Blanco-Canosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nardone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Albericio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Dawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="7197" to="7209" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Characterizing post-translational modifications and their effects on protein conformation using NMR spectroscopy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Narayanan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sekhar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="57" to="73" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Long-range structural preformation in yesassociated protein precedes encounter complex formation with TEAD</title>
		<author>
			<persName><forename type="first">M</forename><surname>Feichtinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Migotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Iscience</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">The ambivalent role of proline residues in an intrinsically disordered protein: from disorder promoters to compaction facilitators</title>
		<author>
			<persName><forename type="first">B</forename><surname>Mateos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Conrad-Billroth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiavina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Biol</title>
		<imprint>
			<biblScope unit="volume">432</biblScope>
			<biblScope unit="page" from="3093" to="3111" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Long-range correlated dynamics in intrinsically disordered proteins</title>
		<author>
			<persName><forename type="first">G</forename><surname>Parigi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rezaei-Ghaleh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Giachetti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Chem Soc</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="16201" to="16209" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Dynamic actin-mediated nano-scale clustering of CD44 regulates its meso-scale organization at the plasma membrane</title>
		<author>
			<persName><forename type="first">P</forename><surname>Sil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mateos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Biol Cell</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="561" to="579" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Simplified screening for the detection of soluble fusion constructs expressed in E. coli using a modular set of vectors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dummler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Lawrence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De Marco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Microb Cell Fact</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">34</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">A method for efficient isotopic labeling of recombinant proteins</title>
		<author>
			<persName><forename type="first">J</forename><surname>Marley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bracken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biomol NMR</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="71" to="75" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Cleavage of structural proteins during the assembly of the head of bacteriophage T4</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">K</forename><surname>Laemmli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">227</biblScope>
			<biblScope unit="page" from="680" to="685" />
			<date type="published" when="1970">1970</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Single posttranslational modifications in the central repeat domains of tau4 impact its aggregation and tubulin binding</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ellmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brehs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haj-Yahya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Lashuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cfw</forename><surname>Becker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew Chem Int Ed Engl</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="1616" to="1620" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
